Kala Bio Chief Executive Mark Iwicki Resigns; Shares Fall

MT Newswires Live
2025/02/13

Kala Bio (KALA) said Wednesday that Mark Iwicki has resigned as chief executive, effective immediately, but will continue to serve as board chair.

The clinical-stage biopharmaceutical company appointed President and Chief Operating Officer Todd Bazemore as interim CEO.

Kala Bio shares were down about 34% in recent trading.

Price: 7.11, Change: -3.77, Percent Change: -34.65

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10